| NCT Number | NCT07474051 |
| Lead Sponsor | AvenCell Therapeutics, Inc.
Collaborators: AvenCell Europe GmbH |
| Conditions | B-cell Lymphoma, Chronic Lymphocytic Leukemia, Hematologic Malignancy, AML (Acute Myelogenous Leukemia), Prostate Cancer |
| Enrollment | 178 participants |
| Start Date | 2026-01-29 |
| Primary Completion | 2040-11-30 (estimated) |
| Study Completion | 2041-01-30 (estimated) |
| Updated on ClinicalTrials.gov | 2026-03-16 |